References
- Kaeda JS, Mills K, Kharas MG, . Increased MSI2 expression is associated with aggressive CML and AML. Blood 2011;118(Suppl. 1): Abstract 2516.
- Ito T, Kwon HY, Zimdahl B, . Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature 2010;466: 765–768.
- Kharas MG, Lengner CJ, Al-Shahrour F, . Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med 2010;16:903–908.
- Imai T, Tokunaga A, Yoshida T, . The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol Cell Biol 2001;21: 3888–3900.
- Marin D, Kaeda J, Szydlo R, . Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse. Leukemia 2005;19:507–512.
- Kaeda J, Derville O, Szydlo RM, . Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplant for chronic myeloid leukemia. An attempt to define patients who may not require further therapy. Blood 2006;107: 4171–4176.
- Reference SNP (refSNP) Cluster Report: rs11625196 [Internet]. NCBI. Available from: http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi? rs = rs11625196
- Reference SNP (refSNP) Cluster Report: rs7202 [Internet]. NCBI. Available from: http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi? rs = rs7202